Manchester life sciences spin-out Imperagen has secured £3.5m in seed investment led by IQ Capital and Northern Gritstone. The IP-rich firm is a spin-out from the University of Manchester led by serial entrepreneur Dr Andrew Almond, who co-founded Conformetrix, now listed on AIM as C4X Discovery. Imperagen will use the funding to support the development … Continue reading Life sciences spin-out Imperagen secures £3.5m seed investment